| # | Drug | Count |
|---|---|---|
| 0 | ASFOTASE ALFA | 6 |
| 1 | CINACALCET | 4 |
| 2 | CINACALCET HYDROCHLORIDE | 3 |
| 3 | BUROSUMAB | 2 |
| 4 | CALCITRIOL | 2 |
| 5 | CALCITRIOL CAPSULES 0.25 MCG | 2 |
| 6 | CALCITRIOL CAPSULES 0.5 MCG | 2 |
| 7 | ADALIMUMAB | 1 |
| 8 | ADALIMUMAB-AATY | 1 |
| 9 | ADALIMUMAB-ADAZ | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 1 | 0.0008 |
| 1 | ASFOTASE ALFA | 6 | 0.0006 |
| 2 | BUROSUMAB | 2 | 0.0003 |
| 3 | IRON SUCROSE | 1 | 0.0001 |
| 4 | CALCITRIOL CAPSULES 0.25 MCG | 2 | 0.0001 |
| 5 | ZIDOVUDINE | 1 | 0.0001 |
| 6 | ATAZANAVIR | 1 | 0.0001 |
| 7 | RITONAVIR 100 MG | 1 | 0.0001 |
| 8 | CINACALCET HYDROCHLORIDE | 3 | 0.0001 |
| 9 | LAMIVUDINE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 6 | 0.0006 |
| 1 | Vitamin D3 Analog [EPC] | 2 | 0.0001 |
| 2 | Parenteral Iron Replacement [EPC] | 1 | 0.0001 |
| 3 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 7 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 8 | Interleukin-12 Antagonist [EPC] | 1 | 0.0000 |
| 9 | Interleukin-23 Antagonist [EPC] | 1 | 0.0000 |